MAPT and Alzheimer disease: They proposed that differences in splicing of the MAPT N‐terminus that exist between AD and PSP result in the expression of isoforms with different aggregation properties and subcellular localizations, which in turn help to explain the distinct neuropathological phenotypes of each disease.